Curated News
By: NewsRamp Editorial Staff
November 26, 2025
Datavault AI Licenses Smart Contracts to Transform Pharmacy Networks
TLDR
- Datavault AI's smart contract licensing gives Wellgistics Health a competitive edge by reducing PBM costs and enhancing transparency across 6,500+ pharmacies.
- Datavault AI's smart contracts integrate with PharmacyChain and EinsteinRx platforms using Web 3.0 technology to automate prescription tracking and pharmaceutical distribution.
- This partnership modernizes pharmaceutical distribution by improving prescription transparency and reducing healthcare costs, creating a more efficient system for patients and providers.
- Datavault AI's Web 3.0 smart contracts now power prescription tracking across 6,500+ pharmacies through Wellgistics' PharmacyChain and EinsteinRx platforms.
Impact - Why it Matters
This partnership represents a significant step toward modernizing the U.S. pharmaceutical supply chain, which has long been plagued by inefficiencies, high costs, and lack of transparency. For consumers, this could mean lower prescription drug prices as the technology reduces PBM-driven costs and streamlines distribution. The integration of Web 3.0 smart contracts into pharmacy operations could also enhance medication safety through improved tracking and reduce administrative burdens that often delay prescription fulfillment. As healthcare costs continue to rise, such technological innovations that address systemic inefficiencies in pharmaceutical distribution could have far-reaching benefits for patients, insurers, and healthcare providers alike.
Summary
Datavault AI Inc. (NASDAQ: DVLT) has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) in a strategic partnership that promises to revolutionize pharmaceutical distribution. This collaboration will integrate Datavault AI's advanced smart contract technology into Wellgistics' PharmacyChain™ and EinsteinRx™ platforms, bringing Web 3.0 capabilities to a network of more than 6,500 pharmacies nationwide. The integration aims to modernize prescription tracking systems, reduce costs driven by Pharmacy Benefit Managers (PBMs), enhance transparency for payers, and streamline pharmaceutical distribution through sophisticated data automation and AI integration.
Datavault AI stands at the forefront of AI experience, valuation, and asset monetization in the Web 3.0 environment, operating through its innovative Acoustic Science and Data Science Divisions. The company's comprehensive cloud-based platform serves multiple industries including healthcare, biotech, fintech, and real estate through technologies like the Information Data Exchange® (IDE) that enables Digital Twins and secure licensing of name, image, and likeness (NIL). This partnership represents a significant milestone in applying Web 3.0 technologies to healthcare infrastructure, leveraging Datavault AI's expertise in high-performance computing, AI automation, and secure data monetization to transform how prescription drugs are tracked and managed across the United States.
The announcement was distributed through the InvestorBrandNetwork's Dynamic Brand Portfolio, which includes specialized communications platforms like AINewsWire that focus on artificial intelligence advancements and innovations. For investors seeking additional information about Datavault AI's developments, the company maintains an active newsroom through the InvestorBrandNetwork platform where stakeholders can access the latest updates and press releases. This strategic licensing agreement demonstrates how cutting-edge Web 3.0 technologies are increasingly being applied to solve real-world challenges in critical sectors like healthcare, potentially setting new standards for efficiency and transparency in pharmaceutical distribution systems.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Datavault AI Licenses Smart Contracts to Transform Pharmacy Networks
